$88.59−0.85%Close 16 Nov 2026 · Market value $110.4B
In its results release of 4 Nov 2026 (Q3 FY2026), CVS HEALTH Corp gave 2 forecasts in figures, among them EPS (gaap) of at least $6.98 for FY2026.
Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.
Latest guidance given with Q3 FY2026 results, 4 Nov 2026
| Measure | Period | Guidance | As stated |
|---|
| EPS · GAAP | FY2026 | At least $6.98 | GAAP diluted EPS guidance to at least $6.98 from a range of $6.84 to $7.04 |
|---|
| EPS · Adjusted | FY2026 | At least $8.20 | Adjusted EPS guidance to at least $8.20 from a range of $7.90 to $8.10 |
|---|
Source: the company's earnings release.
Guidance against results above 1 · within 0 · below 0
The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.
| Measure | Period | Last guidance | Revisions | Delivered | Result |
|---|
| Revenue | FY2026 | At least $400.0B | Given once | — | To come |
|---|
| EPS · GAAP | FY2026 | At least $6.98 | Raised 3 times | — | To come |
|---|
| EPS · Adjusted | FY2026 | At least $8.20 | Raised 3 times | — | To come |
|---|
| Operating income · GAAP | FY2026 | $13.26B to $13.60B | Given once | — | To come |
|---|
| Operating income · Adjusted | FY2026 | $15.07B to $15.41B | Given once | — | To come |
|---|
| Operating cash flow | FY2026 | At least $10.00B | Given once | — | To come |
|---|
| EPS · Adjusted | FY2025 | $6.60 to $6.70 | Raised twice | $6.75 | Above the range |
|---|
CVS in the terminal
Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.